WO2008109500A2 - Nucleic acid compounds for inhibiting prkca ...,https://www.google.com/patents/WO2008109500A2?cl=nl
WO2004022592A1 - Use of human protein kinase c-eta in methods ...,https://www.google.com/patents/WO2004022592A1?cl=es
WO2016011147A1 - Prkc fusions - Google Patents,https://www.google.com/patents/WO2016011147A1?cl=sv
WO2006108270A1 - Inhibitors of protein kinases and uses thereof ...,https://www.google.com/patents/WO2006108270A1?cl=ko
US20060224331A1 - Protein fragment complementation assays for ...,https://www.google.com/patents/US20060224331
WO2015093857A1 - Method for screening agent for preventing or ...,https://www.google.com/patents/WO2015093857A1?cl=en
US20140256649A1 - Protein-protein interaction as biomarkers ...,https://www.google.com/patents/US20140256649
"CA2879359A1 - Screening, diagnosis and prognosis of autism and ...",https://www.google.com/patents/CA2879359A1?cl=de
"WO2008037688A2 - Crystalline forms of pkc alpha kinase, methods ...",https://www.google.com/patents/WO2008037688A2?cl=da
US20170002426A1 - Egfr/nedd9/tgf-beta interactome and methods ...,https://www.google.com/patents/US20170002426
